Probing disease mechanisms in ALS using iPSCs, reprogramming and optogenetic approaches

"New Insights Into Disease Mechanisms of Genetic ALS"Подробнее

Precise Gene Editing of Human Pluripotent Stem CellsПодробнее

Webinar: Stem Cell ReprogrammingПодробнее

Using induced pluripotent stem cells as a platform for ALS Dr. Nicholas John Maragakis, M.DПодробнее

IPSC-Derived Human Neurons: Introduction and ApplicationПодробнее

Harnessing iPSC-derived Cardiac Progenitor Cells and Fibroblasts for Myocardial RepairПодробнее

Stem Cell and Reprogramming Research MethodsПодробнее

The Use of Human iPSC-derived Motor Neurons for Translational ResearchПодробнее

Modeling Barth syndrome using patient-specific, iPSC-derived cardiomyocytesПодробнее

Fred H. Gage: Stem cells for modeling diseaseПодробнее

Reprogramming somatic cells using the Sendai virus technology: ISSCR 2014 – Dr. Laurence DaheronПодробнее

Tools & Strategies for Implementing iPSC-based Cell Models for Neurodegenerative Disease Drug Dis...Подробнее

Addressing the scalability of human iPSC-derived neurons for HTS implementationПодробнее

Keynote Presentation at 2022 Les Turner Symposium on ALSПодробнее

Diabetic Cardiomyopathy Modeling & Screening with iPSC CardiomyocytesПодробнее

RNA-based Reprogramming of Fibroblasts into iPSCs | Protocol PreviewПодробнее

Modeling the human brain using induced pluripotent stem cells iPSCs 1Подробнее

F. Feiguin - Neuronal and extraneuronal mechanism of neurodegeneration in ALSПодробнее

Development of Therapeutic Approaches for Muscle Disease Using Human Pluripotent Stem CellsПодробнее